{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:43:22Z","timestamp":1777884202157,"version":"3.51.4"},"reference-count":49,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2024,10,2]]},"DOI":"10.1080\/03007995.2024.2394602","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:58:20Z","timestamp":1724407100000},"page":"1719-1725","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer\u2019s disease"],"prefix":"10.1080","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7201","authenticated-orcid":false,"given":"Urvi","family":"Desai","sequence":"first","affiliation":[{"name":"Analysis Group, Inc, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-8201","authenticated-orcid":false,"given":"Dumingu Aparna","family":"Gomes","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Menlo Park, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-4025","authenticated-orcid":false,"given":"Julie","family":"Chandler","sequence":"additional","affiliation":[{"name":"Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Ye","sequence":"additional","affiliation":[{"name":"Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Daly","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-6883","authenticated-orcid":false,"given":"Noam","family":"Kirson","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen B.","family":"Dennehy","sequence":"additional","affiliation":[{"name":"Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA"},{"name":"Department of Psychological Sciences, Purdue University, West Lafayette, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,9]]},"reference":[{"key":"e_1_3_5_2_1","volume-title":"2022 Alzheimer\u2019s Disease Facts and Figures.","author":"Alzheimer\u2019s Association","year":"2022","unstructured":"Alzheimer\u2019s Association. 2022 Alzheimer\u2019s Disease Facts and Figures. Chicago, IL: Alzheimer\u2019s Association; 2022."},{"key":"e_1_3_5_3_1","volume-title":"World Alzheimer Report 2022 - Life after diagnosis: navigating treatment, care and support","author":"Alzheimer\u2019s Disease International","year":"2022","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2022 - Life after diagnosis: navigating treatment, care and support. Lincolnshire, IL: Alzheimer's Disease International; 2022."},{"key":"e_1_3_5_4_1","volume-title":"2024 Alzheimer\u2019s Disease Facts and Figures","author":"Alzheimer\u2019s Association","year":"2024","unstructured":"Alzheimer\u2019s Association. 2024 Alzheimer\u2019s Disease Facts and Figures. Chicago, IL: Alzheimer's Association; 2024."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310168"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-32-9358-8_16"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2021.100041"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.5319"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00403-3"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.05.017"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210305"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2007.10.018"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afr101"},{"issue":"2","key":"e_1_3_5_15_1","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein S","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, et\u00a0al. Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9(2):197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205015666180119092427"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0459-7"},{"key":"e_1_3_5_20_1","volume-title":"CTAD) conference","author":"Bateman RJ","year":"2022","unstructured":"Bateman RJ, Smith J, Donohue MC, et\u00a0al. GRADUATE I and II: topline results of two global, phase III, randomized, placebo-controlled studies assessing the efficacy and safety of subcutaneous gantenerumab in early Alzheimer\u2019s disease. 15th Annual Clinical Trials on Alzheimer's Disease (CTAD) conference. San Francisco, CA: CTAD; 2022."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706441"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.2909"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705971"},{"key":"e_1_3_5_25_1","volume-title":"CTAD","author":"Macfarlane S","year":"2022","unstructured":"Macfarlane S, Grimmer T, O'Brien T, et\u00a0al. Top line data of Anavex 2-73 (blarcamesine): Randomized, double-blind, multicenter, placebo-controlled phase 2b\/3 in patients with early Alzheimer\u2019s disease (AD). San Francisco, CA: CTAD; 2022."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03527-0"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics8010012"},{"issue":"11","key":"e_1_3_5_28_1","first-page":"310","article-title":"Potential implications of slowing disease progression in amyloid-positive early Alzheimer\u2019s disease: estimates from real-world data","volume":"2","author":"Chandler J","year":"2024","unstructured":"Chandler J, Done N, Desai U, et\u00a0al. Potential implications of slowing disease progression in amyloid-positive early Alzheimer\u2019s disease: estimates from real-world data. JPrevent Alzheimer\u2019s Dis. 2024;2(11):310\u2013319.","journal-title":"JPrevent Alzheimer\u2019s Dis"},{"key":"e_1_3_5_29_1","unstructured":"Chandler J Ye W Johnston J et\u00a0al. Potential Improvement in caregiver time quality of life and societal costs with slowing early Alzheimer\u2019s disease progression over 36 months: findings from GERAS-US Study. 2024. Under review."},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000342"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00659-6"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00445-0"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00443-2"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3063"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2019.09.018"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01193-z"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01185-z"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12509"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000747"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191291"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2019.08.010"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00706-2"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12876"},{"issue":"2","key":"e_1_3_5_44_1","article-title":"Disease progression and costs at the 3-year follow-up of the GERAS-US study","volume":"15","author":"Chandler J","year":"2023","unstructured":"Chandler J, Rentz D, Zagar A, et\u00a0al. Disease progression and costs at the 3-year follow-up of the GERAS-US study. Alzheimer\u2019s Dement. 2023;15(2):e12430.","journal-title":"Alzheimer\u2019s Dement"},{"key":"e_1_3_5_45_1","article-title":"Lecanemab for the treatment of early Alzheimer\u2019s disease: topline efficacy results from Clarity AD","author":"Van Dyck CH.","year":"2022","unstructured":"Van Dyck CH. Lecanemab for the treatment of early Alzheimer\u2019s disease: topline efficacy results from Clarity AD. 15th Annual Clinical Trials on Alzheimer's Disease (CTAD) conference. San Francisco, CA: CTAD; 2022.","journal-title":"CTAD) conference"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160449"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610217001211"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000461577"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191212"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-231166"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2024.2394602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T15:24:51Z","timestamp":1728487491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2024.2394602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,2]]}},"alternative-id":["10.1080\/03007995.2024.2394602"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2024.2394602","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}